ZENITH EPIGENETICS
Zenith Epigenetics is a research and development biotechnology company focused on new and innovative drugs by leveraging its proprietary epigenetics platform. The company's epigenetic drug discovery platform functions by inhibiting BET bromodomains, having the potential to impact multiple diseases including autoimmune and oncology.
ZENITH EPIGENETICS
Social Links:
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2013-01-01
Address:
Calgary, Alberta, Canada
Country:
Canada
Website Url:
http://www.zenithepigenetics.com
Total Employee:
11+
Status:
Active
Contact:
(403) 254-9252
Email Addresses:
[email protected]
Total Funding:
16.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Font Awesome HSTS IPv6 Common Name Invalid Microsoft DigiCert SSL Typekit AddThis
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
CiVi Biopharma
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.
freedomest
freedomest offers therapies and treatments that focus on people who addicted to drugs in Egypt.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.zenithepigenetics.com Semrush global rank: 9.04 M Semrush visits lastest month: 445
- Host name: 159.203.49.164
- IP address: 159.203.49.164
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "Zenith Epigenetics"
Overview - zenithepigenetics
[email protected] Call 1 (587) 390-7865 Share FAQ; About. Overview; Management; Board of Directors; Overview. Zenith Epigenetics’ experienced research team has developed a …See details»
Zenith Epigenetics - Crunchbase Company Profile
Organization. Zenith Epigenetics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Zenith Epigenetics is a research and development biotechnology company focused …See details»
Management - zenithepigenetics
[email protected] Call 1 (587) 390-7865 Share FAQ; About. Overview; Management; Board of Directors; Management. Donald J. McCaffrey President and Chief Executive Officer. …See details»
Zenith Epigenetics Ltd. | LinkedIn
Zenith Epigenetics Ltd. | 1,031 followers on LinkedIn. Zenith Epigenetics Ltd. is a clinical stage biotechnology company developing best in class bromodomain (BET) inhibitors for the …See details»
Zenith Epigenetics Ltd. | LinkedIn
Zenith Epigenetics Ltd. is a clinical stage biotechnology company developing best in class bromodomain (BET) inhibitors for the treatment of cancer and other disorders with significant unmet ...See details»
Zenith Epigenetics Ltd. | VentureRadar
Website: https://www.zenithepigenetics.com. Develops best-in-class bromodomain inhibitors for cancer treatment, aiming to be a leading epigenetic company translating bromodomain biology …See details»
Zenith Epigenetics Corp. - Employees, Contact info, Overview - Wiza
May 1, 2024 View info about Zenith Epigenetics Corp. (zenithepigenetics.com). Zenith Epigenetics Corp. is a company located in Calgary, AB, Canada. Find employees, official …See details»
Zenith Epigenetics Ltd. Announces Collaboration with …
Oct 25, 2023 Calgary, Alberta--(Newsfile Corp. - October 25, 2023) - Zenith Epigenetics Ltd. ("Zenith" or the "Company"), a global leader in epigenetics, announced today it has entered into an agreement with ...See details»
Board of Directors - zenithepigenetics
Dr. Thompson is an experienced biotechnology founder and executive having served as a public company CEO for 22 years. He has served as Chairman, Director, and an Audit Committee …See details»
Zenith Epigenetics Ltd. information - Employees, Contact info
View information on-Zenith Epigenetics Ltd. (zenithepigenetics.com),Located in . Find over 10 employees information, adress, official website, private emails, phone numbers, revenue, …See details»
Zenith Epigenetics Announces Dosing of First Cancer Patient with …
Feb 22, 2022 Zenith Capital Corp. is a biotechnology investment company originally spun out of Resverlogix Corp. (TSX: RVX) in 2013. Zenith Epigenetics Ltd., a wholly-owned subsidiary of …See details»
Zenith Epigenetics Announces Start of Several National Cancer …
Jul 6, 2022 Combination with immune-checkpoint inhibitors. NCT04840589 (enrolling) A Phase I/Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694 With PD-1 Inhibitor, …See details»
News Releases - zenithepigenetics
Oct 25, 2023 Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical …See details»
Zenith Epigenetics Announces Dosing of First mCRPC Patient
Mar 15, 2021 Website: www.zenithepigenetics.com. This news release may contain certain forward-looking information as defined under applicable Canadian securities legislation, that …See details»
Zenith Epigenetics Triple Negative Breast Cancer Clinical
Jun 21, 2022 GRASP, which stands for Guiding Researchers and Advocates for Scientific Partnerships, is a patient-led organization that brings together patients, clinicians, and …See details»
Zenith Epigenetics Announces Initiation of a Phase 2b Triple …
May 10, 2022 Data from the completed Phase 1b/2 trial to be presented at the American Society of Clinical Oncology (ASCO) Conference in an oral poster discussion sessionCALGARY, …See details»
News Releases - zenithepigenetics
Jan 31, 2022 [email protected] Call 1 (587) 390-7865 Share FAQ; Newsroom. News Releases; Presentations & Events; SEDAR Filings; News Releases. Print Version Zenith …See details»
News Releases - zenithepigenetics
Feb 29, 2024 [email protected] Call 1 (587) 390-7865 Share FAQ; Newsroom. News Releases; Presentations & Events; SEDAR Filings; News Releases. 2024 2023 2022 2021 …See details»
Zenith Epigenetics Triple Negative Breast Cancer Clinical Data ...
Jun 21, 2022 Zenith’s ASCO Poster was Also Awarded the GRASP Advocate Choice Award by a Patient Advocacy GroupCALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Zenith …See details»